Skip to main content
. 2018;19(7):1987–1991. doi: 10.22034/APJCP.2018.19.7.1987

Table 2.

Prevalence of T.gondii in Cancer Patients According to the Origin of Neoplasm and Type of Treatment

Positive Negative OR*
Number % Number %
Solid tumors (total=100) 24 24% 76 76% 3.6
Haematological malignancies (total=50) 6 12% 44 88% 1.5
Radiotherapy (total=50) 10 20% 40 80% 2.9
Chemotherapy (total=100) 20 20% 80 80% 2.8
*

OR, Odds Ratio